In the past few years, based on programmed death-1/programmed death ligand-1 (PD-1/PD-L1) blockade, immune checkpoint inhibitors (ICIs) enriched the thoughts for the treatment of patients with cancer, include NPC [5, 6]. The gene discussed is CD274; the disease is nasopharyngeal carcinoma.